| Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria (NCT00557518) | Synvista Therapeutics, Inc | 2007-11-01 |
| Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study (NCT00497666) | Assaf-Harofeh Medical Center | 2007-08-01 |
| To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN) (NCT00518362) | Nanjing University School of Medicine | 2007-07-01 |
| Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program (NCT00498147) | Group Health Centre | 2007-07-01 |
| Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN) (NCT00708981) | Cook County Health | 2007-05-01 |
| Adiponectin in Obese Women With T2DN and Effects by RAS Blocker (NCT00561704) | Shanghai Jiao Tong University School of Medicine | 2007-04-01 |
| Adiponectin and Insulin Resistance in Diabetic Nephropathy (NCT00774904) | Xi'an Jiaotong University | 2007-04-01 |
| Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong (NCT00462202) | Keryx Biopharmaceuticals | 2007-04-01 |
| The Effects of Bindarit in Diabetic Nephropathy (NCT01109212) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2007-03-01 |
| Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy (NCT00738660) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2007-02-01 |
| Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects (NCT00544934) | Glycadia | 2007-02-01 |
| Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy (NCT00556465) | Shiraz University of Medical Sciences | 2007-01-01 |
| Eplerenone, ACE Inhibition and Albuminuria (NCT00315016) | Radboud University Medical Center | 2007-01-01 |
| The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors (NCT00421733) | Abbott | 2006-12-01 |
| Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN) (NCT00363987) | Fresenius Kabi | 2006-05-01 |
| Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy (NCT00312780) | Symphony Evolution, Inc. | 2006-03-01 |
| Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy (NCT00663949) | Shiraz University of Medical Sciences | 2006-02-01 |
| 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria (NCT00287183) | Pfizer | 2006-02-01 |
| Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy (NCT00361023) | Shanghai Jiao Tong University School of Medicine | 2006-01-01 |
| Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy (NCT00253786) | Okayama University | 2005-11-11 |
| Nephropathy In Type 2 Diabetes and Cardio-renal Events (NCT00535925) | University of Campania Luigi Vanvitelli | 2005-10-01 |
| Effect of Sulodexide in Early Diabetic Nephropathy (NCT00130208) | Keryx Biopharmaceuticals | 2005-08-01 |
| Effect of Sulodexide in Overt Diabetic Nephropathy (NCT00130312) | Keryx Biopharmaceuticals | 2005-08-01 |
| Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) (NCT00296296) | Stanford University | 2005-06-01 |
| Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease (NCT00118976) | Steno Diabetes Center Copenhagen | 2005-03-01 |
| Pioglitazone and Losartan Provides Additional Renoprotection (NCT00364988) | Shanghai Jiao Tong University School of Medicine | 2005-01-01 |
| Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy (NCT00914524) | Daiichi Sankyo Co., Ltd. | 2005-01-01 |
| Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients. (NCT01875341) | Ottawa Hospital Research Institute | 2004-12-01 |
| Antiproteinuric Effect of Valsartan and Lisinopril (NCT00171574) | Novartis | 2004-11-01 |
| Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria (NCT00097955) | Novartis Pharmaceuticals | 2004-10-01 |
| SLC2A1 Variants and Diabetic Nephropathy (NCT01768611) | University of Sao Paulo General Hospital | 2004-10-01 |
| Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy (NCT00782847) | DiaNe HCM GmbH | 2004-07-01 |
| Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study (NCT00222846) | University of Pittsburgh | 2004-05-01 |
| Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes (NCT00419484) | Dokkyo Medical University | 2004-03-01 |
| A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril (NCT00171119) | Novartis Pharmaceuticals | 2004-01-01 |
| Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease. (NCT00240019) | Stanford University | 2003-12-01 |
| Spironolactone in Diabetic Nephropathy (NCT00317954) | Steno Diabetes Center Copenhagen | 2003-09-01 |
| Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes (NCT00063583) | Sharma, Kumar, M.D. | 2003-06-01 |
| Olmesartan Medoxomil and Diabetic Nephropathy (NCT00362960) | Sankyo Pharma Gmbh | 2003-05-01 |
| Treatment of Diabetic Nephropathy (NCT00065559) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-04-01 |
| ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial (NCT00141453) | Daiichi Sankyo Co., Ltd. | 2003-04-01 |
| Matrix Metalloproteinases and Diabetic Nephropathy (NCT00067886) | Arkansas Children's Hospital Research Institute | 2003-03-01 |
| Chicken-Diet vs. Enalapril to Reduce Albuminuria (NCT00484068) | Hospital de Clinicas de Porto Alegre | 2003-01-01 |
| Spironolactone for Reducing Proteinuria in Diabetic Nephropathy (NCT00498537) | US Department of Veterans Affairs | 2003-01-01 |
| Angiotensin II Antagonism of TGF-Beta 1 (NCT00320970) | Providence Health & Services | 2002-08-01 |
| The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes (NCT00044148) | Chromaderm, Inc. | 2002-07-16 |
| Effect of Pyridorin in Patients With Diabetic Nephropathy (NCT00320021) | BioStratum | 2002-07-01 |
| European Trial of Immunosuppression in SPK Tx (NCT00140543) | EUROSPK Study Group | 2002-02-01 |
| Effect of Pyridorin in Patients With Diabetic Nephropathy (NCT00320060) | BioStratum | 2001-10-01 |
| Soy Protein in Early Diabetic Nephropathy (NCT00067678) | National Center for Complementary and Integrative Health (NCCIH) | 2001-07-01 |
| Family Investigation of Nephropathy and Diabetes (F.I.N.D.) (NCT00342927) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2001-03-07 |
| The Family Investigation of Nephropathy and Diabetes Study (NCT00301249) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-10-01 |
| Renoprotection in Early Diabetic Nephropathy in Pima Indians (NCT00340678) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1995-08-01 |
| Delaying the Progression of Diabetic Nephropathy in Pima Indians (NCT00353600) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1994-08-19 |
| Sex-specific Association With Kidney Disease (NCT01810822) | University of Sao Paulo General Hospital | 1994-05-01 |
| Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes (NCT00004266) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1993-08-01 |
| Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy (NCT00311870) | Steno Diabetes Center Copenhagen | 1993-03-01 |
| Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) (NCT00594152) | Joslin Diabetes Center | 1993-01-01 |
| The Genetics of Kidneys in Diabetes (GoKinD) Study (NCT00024921) | National Center for Research Resources (NCRR) | |
| Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout (NCT02327754) | Sanwa Kagaku Kenkyusho Co., Ltd. | |